دورية أكاديمية
أعرض في EDS

COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit Patients from Poland.

التفاصيل البيبلوغرافية
العنوان: COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit Patients from Poland.
المؤلفون: Skóra M; Chair of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, Czysta 18 Street, 31-121 Krakow, Poland., Gajda M; Chair of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, Czysta 18 Street, 31-121 Krakow, Poland., Namysł M; Department of Microbiology, University Hospital in Krakow, Macieja Jakubowskiego 2 Street, 30-688 Krakow, Poland., Wordliczek J; Interdisciplinary Intensive Care Clinic, Jagiellonian University Medical College, Macieja Jakubowskiego 2 Street, 30-688 Krakow, Poland., Zorska J; Center for Innovative Medical Education, Jagiellonian University Medical College, Medyczna 7 Street, 30-688 Krakow, Poland.; Intensive Care Unit, University Hospital in Krakow, Macieja Jakubowskiego 2 Street, 30-688 Krakow, Poland., Piekiełko P; Department of Internal Diseases and Circulatory Failure, Center of Pulmonology and Thoracic Surgery in Bystra, Juliana Fałata 2 Street, 43-360 Bystra, Poland.; Department of Pulmonology and Respiratory Failure, Center of Pulmonology and Thoracic Surgery in Bystra, Juliana Fałata 2 Street, 43-360 Bystra, Poland., Żółtowska B; Center for Innovative Therapy, Clinical Research Coordination Center, University Hospital in Krakow, Macieja Jakubowskiego 2 Street, 30-688 Krakow, Poland., Krzyściak P; Chair of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, Czysta 18 Street, 31-121 Krakow, Poland., Heczko PB; Chair of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, Czysta 18 Street, 31-121 Krakow, Poland., Wójkowska-Mach J; Chair of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, Czysta 18 Street, 31-121 Krakow, Poland.
المصدر: Journal of fungi (Basel, Switzerland) [J Fungi (Basel)] 2023 Jun 13; Vol. 9 (6). Date of Electronic Publication: 2023 Jun 13.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101671827 Publication Model: Electronic Cited Medium: Internet ISSN: 2309-608X (Electronic) Linking ISSN: 2309608X NLM ISO Abbreviation: J Fungi (Basel) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG, [2015]-
مستخلص: Coronavirus disease 2019 (COVID-19) has been shown to be a favoring factor for aspergillosis, especially in a severe course requiring admission to the intensive care unit (ICU). The aim of the study was to assess the morbidity of CAPA among ICU patients in Poland and to analyze applied diagnostic and therapeutic procedures. Medical documentation of patients hospitalized at the temporary COVID-19 dedicated ICU of the University Hospital in Krakow, Poland, from May 2021 to January 2022 was analyzed. In the analyzed period, 17 cases of CAPA were reported with an incidence density rate of 9 per 10 000 patient days and an incidence rate of 1%. Aspergillus fumigatus and Aspergillus niger were isolated from lower respiratory samples. Antifungal therapy was administered to 9 patients (52.9%). Seven patients (77.8%) received voriconazole. The CAPA fatality case rate was 76.5%. The results of the study indicate the need to increase the awareness of medical staff about the possibility of fungal co-infections in ICU patients with COVID-19 and to use the available diagnostic and therapeutic tools more effectively.
References: Clin Infect Dis. 2021 Dec 6;73(11):e3606-e3614. (PMID: 32719848)
Mycoses. 2022 Apr;65(4):411-418. (PMID: 35138675)
Expert Rev Respir Med. 2018 Aug;12(8):651-663. (PMID: 29958019)
Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. (PMID: 29544767)
Crit Care. 2006 Feb;10(1):R31. (PMID: 16507158)
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629. (PMID: 32711058)
Lancet Respir Med. 2018 Oct;6(10):782-792. (PMID: 30076119)
J Fungi (Basel). 2022 Jan 18;8(2):. (PMID: 35205848)
Pol Arch Intern Med. 2022 May 30;132(5):. (PMID: 35238324)
Rev Clin Esp (Barc). 2021 Aug-Sep;221(7):430-431. (PMID: 34103278)
Clin Microbiol Infect. 2012 Dec;18 Suppl 7:9-18. (PMID: 23137134)
J Fungi (Basel). 2020 Jun 24;6(2):. (PMID: 32599813)
Am J Respir Crit Care Med. 2012 Jul 1;186(1):56-64. (PMID: 22517788)
Clin Microbiol Infect. 2022 Jul;28(7):920-927. (PMID: 35150878)
Lancet Respir Med. 2020 Jun;8(6):e48-e49. (PMID: 32445626)
Chron Respir Dis. 2008;5(1):19-27. (PMID: 18303098)
Lancet Infect Dis. 2021 Jun;21(6):e149-e162. (PMID: 33333012)
BMC Pulm Med. 2015 Sep 29;15:107. (PMID: 26420333)
Crit Care. 2021 Sep 26;25(1):348. (PMID: 34565429)
Mycoses. 2021 Sep;64(9):1002-1014. (PMID: 33760284)
Eur Respir J. 2016 Mar;47(3):954-66. (PMID: 26743480)
Curr Fungal Infect Rep. 2020;14(4):378-383. (PMID: 33312332)
Clin Infect Dis. 2020 Jul 28;71(15):762-768. (PMID: 32161940)
Trends Parasitol. 2021 Oct;37(10):859-862. (PMID: 34364804)
Mycoses. 2021 Sep;64(9):980-988. (PMID: 34143533)
Clin Infect Dis. 2016 Aug 15;63(4):e1-e60. (PMID: 27365388)
Mycoses. 2020 Jun;63(6):528-534. (PMID: 32339350)
J Infect. 2020 Aug;81(2):266-275. (PMID: 32473235)
Mycoses. 2021 Nov;64(11):1317-1327. (PMID: 34387004)
Infect Dis Ther. 2020 Sep;9(3):511-524. (PMID: 32638227)
J Fungi (Basel). 2020 Nov 18;6(4):. (PMID: 33217952)
Clin Infect Dis. 2020 Sep 12;71(6):1367-1376. (PMID: 31802125)
Diagn Microbiol Infect Dis. 2018 Jun;91(2):147-152. (PMID: 29454654)
Clin Infect Dis. 2021 Oct 5;73(7):e1634-e1644. (PMID: 32860682)
Clin Infect Dis. 1998 Apr;26(4):781-803; quiz 804-5. (PMID: 9564455)
Eur Respir J. 2022 May 5;59(5):. (PMID: 35144992)
Am J Respir Crit Care Med. 2017 Apr 7;196(4):524-527. (PMID: 28387526)
Mycoses. 2021 Feb;64(2):132-143. (PMID: 33210776)
Infect Dis Clin North Am. 2021 Jun;35(2):415-434. (PMID: 34016284)
Ann Intensive Care. 2021 Mar 8;11(1):41. (PMID: 33683480)
Mycoses. 2022 May;65(5):541-550. (PMID: 35212030)
Med Mycol. 2020 Jun 1;58(4):444-452. (PMID: 31290552)
Nat Microbiol. 2022 Aug;7(8):1127-1140. (PMID: 35918423)
Head Neck. 2020 Jul;42(7):1634-1637. (PMID: 32348600)
Eur Respir J. 2015 May;45(5):1463-78. (PMID: 25792631)
Crit Care. 2020 Nov 10;24(1):642. (PMID: 33168049)
Am J Respir Crit Care Med. 2008 Jan 1;177(1):27-34. (PMID: 17885264)
Crit Care. 2015 Apr 17;19:178. (PMID: 25927915)
معلومات مُعتمدة: National Centre for Resear"Support for specialist hospitals in fighting the spread of SARS-CoV-2 infection and in treating COVID-19" (contract number: SZPITALE-JEDNOIMIENNE/18/2020) National Centre for Research and Development; U1C/W41/NO/28.23 Jagiellonian University Medical College
فهرسة مساهمة: Keywords: Aspergillus; CAPA; COVID-associated pulmonary aspergillosis; SARS-CoV-2; invasive aspergillosis
تواريخ الأحداث: Date Created: 20230627 Latest Revision: 20230701
رمز التحديث: 20230701
مُعرف محوري في PubMed: PMC10303628
DOI: 10.3390/jof9060666
PMID: 37367602
قاعدة البيانات: MEDLINE
الوصف
تدمد:2309-608X
DOI:10.3390/jof9060666